Professor
University of California, San Francisco
Disclosure(s): Basilea Pharmaceutica: Grant/Research Support; F2G Limited: Grant/Research Support; Genentech: Advisor/Consultant; Gilead Biosciences: Grant/Research Support; Janssen/J+J: Advisor/Consultant; Pfizer, Inc: Grant/Research Support; Regeneron, Inc: Grant/Research Support; Shinogi: Grant/Research Support
Sarah Doernberg is a Professor in the Division of Infectious Diseases at the University of Califonia, San Francisco. She has an active outpatient Infectious Diseases Clinic and sees inpatients on the Transplant Infectious Diseases service. Her clinical research focuses on diagnosis and treatment of antibiotic resistant infections and antimicrobial stewardship.